Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Announces Agreement with BARDA for the Manufacturing and Testing of New Antibodies Against MERS Virus

08/22/16

TARRYTOWN, N.Y., Aug. 22, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) to manufacture and study two antibody therapies...

Read more

Upcoming Events

36th Annual Canaccord Genuity Growth Conference

08/11/16 at 11:30 AM ET

View Event

Regeneron Pharmaceuticals Q2 2016 Earnings Conference Call

08/04/16 at 8:30 AM ET

View Event




Close
Form content here please :)